SCHEMBL5564985

SCHEMBL5564985

COc1cc2c(Oc3cc(Cc4ccccc4)[nH]n3)ncnc2cc1OCCCN1CCOCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 9/20 0.55
KIT P10721 2/20 0.53
KDM1A O60341 1/20 0.53
MAP2K1 Q02750 2/20 0.52
KDR P35968 6/20 0.51
EGFR P00533 4/20 0.51
AURKA O14965 3/20 0.51
AURKB Q96GD4 3/20 0.51
PDGFRB P09619 2/20 0.51
FLT4 P35916 2/20 0.51
TEK Q02763 2/20 0.51
ROCK2 O75116 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LCK P06239 1/20 0.51
FYN P06241 1/20 0.51
RET P07949 1/20 0.51
MET P08581 1/20 0.51
MAPT P10636 1/20 0.51
PDGFRA P16234 1/20 0.51
LTK P29376 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5562087 0.93 SRC (0.55) SRCKITKDM1AMAP2K1KDR
SCHEMBL5566275 0.89 KDM1A (0.57) SRCKITKDM1AKDREGFR
SCHEMBL5567304 0.89 KDM1A (0.57) SRCKITKDM1AKDREGFR
SCHEMBL5565918 0.87 SRC (0.57) SRCKDM1AMAP2K1KDREGFR
SCHEMBL5567176 0.87 KDM1A (0.55) SRCKITKDM1AKDREGFR
Hydrochloric Acid SCHEMBL5566627 0.87 SRC (0.56) SRCKDM1AMAP2K1KDREGFR
SCHEMBL5566463 0.86 AURKA (0.58) SRCKITKDM1AKDREGFR
SCHEMBL5566389 0.86 KDM1A (0.55) SRCKITKDM1AKDREGFR
SCHEMBL5566886 0.84 KDM1A (0.53) SRCKITKDM1AKDREGFR
SCHEMBL5560438 0.84 KDM1A (0.53) SRCKITKDM1AKDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 US disclosed
EP-1119567-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-05-04 EP disclosed
EP-1119567-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2001-08-01 EP disclosed
WO-2000021955-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2000-04-20 WO disclosed